GALECTIN THERAPEUTICS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Galectin Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Galectin Therapeutics Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$9.07M, a 1.09% increase year-over-year.
  • Galectin Therapeutics Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$39.6M, a 1.08% decline year-over-year.
  • Galectin Therapeutics Inc annual Operating Income (Loss) for 2023 was -$38.1M, a 0.73% increase from 2022.
  • Galectin Therapeutics Inc annual Operating Income (Loss) for 2022 was -$38.4M, a 27.1% decline from 2021.
  • Galectin Therapeutics Inc annual Operating Income (Loss) for 2021 was -$30.2M, a 28.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$39.6M -$9.07M +$100K +1.09% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$39.7M -$11.3M -$2.29M -25.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$37.4M -$9.65M +$694K +6.71% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$38.1M -$9.56M +$1.07M +10.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$39.1M -$9.17M -$1.04M -12.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$38.1M -$9M +$659K +6.82% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$38.8M -$10.3M -$407K -4.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$38.4M -$10.6M -$3.21M -43.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$35.1M -$8.12M +$122K +1.48% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$35.3M -$9.66M -$1.47M -17.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$33.8M -$9.94M -$3.62M -57.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$30.2M -$7.43M +$407K +5.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$30.6M -$8.24M -$2.32M -39.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$28.3M -$8.19M -$2.09M -34.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$26.2M -$6.32M -$2.73M -76.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$23.4M -$7.83M -$2.64M -51% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$20.8M -$5.93M -$3.06M -107% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$17.7M -$6.1M -$3.08M -102% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$14.7M -$3.58M -$1.22M -51.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$13.4M -$5.19M -$2.2M -73.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$11.2M -$2.86M -$183K -6.83% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$11.1M -$3.02M +$739K +19.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$11.8M -$2.37M +$1.81M +43.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$13.6M -$2.99M -$612K -25.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$13M -$2.68M +$1.73M +39.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$14.7M -$3.76M +$755K +16.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$15.5M -$4.18M +$768K +15.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$16.2M -$2.37M +$2.23M +48.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$18.5M -$4.41M +$123K +2.71% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$18.6M -$4.51M +$1.02M +18.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$19.6M -$4.95M +$1.87M +27.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$21.5M -$4.6M +$84K +1.79% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 -$21.6M -$4.54M +$1.36M +23.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$22.9M -$5.53M -$874K -18.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$22.1M -$6.81M -$1.97M -40.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$20.1M -$4.68M -$949K -25.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-28
Q3 2015 -$19.1M -$5.9M -$2.42M -69.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$16.7M -$4.66M -$1.28M -38% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$15.4M -$4.84M +$4K +0.08% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$15.4M -$3.73M -$930K -33.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$14.5M -$3.48M +$68K +1.92% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$14.6M -$3.38M -$828K -32.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$13.7M -$4.84M -$1.64M -51% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$12.1M -$2.8M -$422K -17.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 -$11.7M -$3.55M -$649K -22.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$11M -$2.55M +$121K +4.54% Mar 30, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$11.2M -$3.21M -$1.26M -64.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 -$9.9M -$2.38M +$990K +29.4% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-18
Q3 2012 -$10.9M -$2.9M -$863K -42.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$10M -$2.67M +$323K +10.8% Mar 29, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$10.3M -$1.95M +$60K +2.98% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$10.4M -$3.37M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-29
Q3 2011 -$2.03M -$821K -67.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$2.99M -$1.64M -122% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-10
Q1 2011 -$2.01M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 -$1.21M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$1.35M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.